ARTL
Artelo Biosciences Inc
Halal Rating :
Last Price
$1.16
Last updated:
Market Cap
-
7D Change
0.87%
1 Year Change
-16.55%
Company Overview
Industries
Exchange
Next Earnings Date
Artelo Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics targeting the endocannabinoid system. The company's main pipeline includes ART27.13 for cancer-related anorexia, ART26.12 for cancer treatment, and ART12.11 for inflammatory diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Artelo Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.